| Business Summary | | Coram
Healthcare
Corporation
(CHC)
and
its
subsidiaries
are
engaged
primarily
in
the
business
of
furnishing
alternate
site
(outside
the
hospital)
infusion
therapy,
including
non-intravenous
home
health
products
such
as
durable
medical
equipment
and
respiratory
services.
Other
services
offered
by
Coram
include
centralized
management,
administration
and
clinical
support
for
clinical
research
trials.
Coram
delivers
its
alternate
site
infusion
therapy
services
through
76
branch
offices
located
in
40
states
and
Ontario,
Canada.
Coram
provides
a
variety
of
infusion
therapies,
principally
nutrition,
anti-infective
therapies
and
intravenous
immunoglobulin,
as
well
as,
coagulant
and
blood-clotting
therapies
for
patients
with
hemophilia.
CHC
and
its
wholly
owned
subsidiary,
Coram,
Inc.,
filed
voluntary
petitions
under
Chapter
11
of
the
United
States
Bankruptcy
Code
on
August
8,
2000. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CRHEQ
provides
alternate
site
infusion
therapy
and
related
services,
ancillary
network
management
services,
and
pharmacy
benefit
management
and
specialty
mail-order
pharmacy
services.
For
the
six
months
ended
6/30/01,
revenues
fell
27%
to
$193.7
million.
Net
loss
from
continuing
operations
fell
19%
to
$4.4
million.
Revenues
reflect
the
sale
of
the
CPS
business
and
lower
infusion
income.
Lower
loss
reflects
higher
margins
and
a
$583
thousand
restructuring
cost
recovery. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Daniel Crowley, 52 Chairman,
Pres and CEO | $50K | Joseph Smith, 41 COO | 312K | Allen Marabito, 53 Exec.
VP | -- | Scott Danitz, 42 Sr.
VP-Fin., CAO | 233K | Scott Larson, 37 Sr.
VP, Gen. Counsel and Sec. | 185K | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|